-
Mashup Score: 0Home - 11 hour(s) ago
Thursday, 13 June, 2024 5:00 – 6:30 PM CEST Room Name: Dali 2 Hall IFEMA Madrid Recinto Ferial (Fairgrounds) Av. del Partenón, 5, Barajas, 28042 Madrid, Spain Hybrid Join us for a symposium on patient-centered care using asparaginase therapies for acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL), designed to encourage the exchange of ideas between leaders in the field and attendees. This symposium will be offered both in-person and virtually. PLEASE NOTE: Only registered attendees of EHA can
Source: events.medscapelive.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase inhibitor (TKI) therapies in a manner that considers the patient’s status, strategically allows for an increased time on therapy, and optimizes the mechanism of action of agents to the patient’s previous therapy response patterns. Faculty Marc Peeters, MD, PhD Kanwal P. S. Raghav, MBBS, MD This event is supported by an independent educational grant from Bayer
Source: www.linkedin.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase inhibitor (TKI) therapies in a manner that considers the patient’s status, strategically allows for an increased time on therapy, and optimizes the mechanism of action of agents to the patient’s previous therapy response patterns. Faculty Marc Peeters, MD, PhD Kanwal P. S. Raghav, MBBS, MD This event is supported by an independent educational grant from Bayer
Source: www.linkedin.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase inhibitor (TKI) therapies in a manner that considers the patient’s status, strategically allows for an increased time on therapy, and optimizes the mechanism of action of agents to the patient’s previous therapy response patterns. Faculty Marc Peeters, MD, PhD Kanwal P. S. Raghav, MBBS, MD This event is supported by an independent educational grant from Bayer
Source: www.linkedin.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Home - 17 day(s) ago
Supported by an independent educational grant from Servier. Join us for an interactive a nd engaging symposium that takes a deep dive into the latest clinical evidence for novel therapies targeting IDH -mutant gliomas and how this can be translated into clinical practice, including expert perspectives on providing individualized, comprehensive care that maximizes long-term outcomes for your patients. Chief, Division of Neuro-Oncology Boston, Massachusetts, United States Miami, Florida, United
Source: events.medscapelive.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Advancements in Breast Cancer Treatment | PBCC 2024 - 18 day(s) ago
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer care and research.
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Home - 19 day(s) ago
Register Now Thursday, May 23, 2024 Time: 11:30 – 12:15 pm ET / 5:30 – 6:15 pm CET CME | CNE | CPE Virtual The therapeutic landscape for treating relapsed/refractory chronic lymphocytic leukemia (R/R CLL) is rapidly evolving, with numerous trials and approvals leading to the availability of multiple treatment options. Though this range of therapies enables the individualization of treatment for patients, it also creates a need to establish optimal treatment sequencing. In this live virtual event, experts
Source: events.medscapelive.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Advancements in Breast Cancer Treatment | PBCC 2024 - 20 day(s) ago
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer care and research.
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Advancements in Breast Cancer Treatment | PBCC 2024 - 21 day(s) ago
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer care and research.
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Home - 21 day(s) ago
Friday, May 3, 2024 | 1:30 pm – 2:30 pm CT Supported by an independent educational grant from Servier. Three pioneers in awake brain surgery, in collaboration with a person living with diffuse low-grade glioma (LGG), will take the audience on a 60-minute journey, from first consultation to the theatre, and beyond. After an update on current and emerging strategies for the management of lower-grade gliomas, key insights on how to optimize tumor resection while preserving patients’ neurological function
Source: events.medscapelive.orgCategories: General Medicine News, Onc News and JournalsTweet
🔬 Understand therapeutic monitoring for ALL/LBL patients on asparaginase therapies. Recognize associated toxicities and select the best treatment approach. Manage treatment and communicate effectively with patients and families 💬 https://t.co/GN5hKqWaBJ https://t.co/CTqqpdmolY